检索结果-南通市图书馆

Astrodynamics 2021年第2期5卷 183-183页

作者： Yusuke Oki Kent Yoshikawa Hiroshi Takeuchi Shota kikuchi Hitosi Ikeda Daniel J.Scheeres Jay W.McMahon Junichiro Kawaguchi Yuto Takei Yuya Mimasu Naoko Ogawa Go Ono Fuyuto Terui Manabu Yamada Toru Kouyama Shingo Kameda Kazuya Yoshida Kenji Nagaoka Tetsuo Yoshimitsu Takanao Saiki Yuichi Tsuda Japan Aerospace Exploration Agency Tsukuba305-8505Japan Japan Aerospace Exploration Agency Sagamihara252-5210Japan University of Colorado BoulderCO80309USA Planetary Exploration Research Center Chiba Institute of TechnologyNarashino275-0016Japan National Institute of Advanced Industrial Science and Technology Koto-ku135-0064Japan Rikkyo University Toshima-ku171-8501Japan Department of Aerospace Engineering Tohoku UniversitySendai980-8579Japan Kyushu Institute of Technology Kitakyusyu804-8550Japan

Correction to:Oki,Y.,Yoshikawa,K.,Takeuchi,*** *** insertion strategy of Hayabusa2's rover with large release uncertainty around the asteroid *** 2020,4(4):309-329 https://***/10.1007/s42064-020-0080-y The article“Orbit insertion strategy of Hayabusa2’s rover with large release uncertainty around the asteroid Ryugu”written by Yusuke Oki,Kent Yoshikawa,Hiroshi Takeuchi et al.,was originally published electronically on the publisher’s internet portal(currently SpringerLink)on 05 November 2020 without open *** publication in Volume 4,Issue 4,page 309–329,the author(s)decided to opt for Open Choice and to make the article an open access publication.

关键词： asteroid insertion release

深部浸润低恶性MALT结肠淋巴瘤在抗生素治疗后的消退:超声内镜评估

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

世界核心医学期刊文摘（胃肠病学分册） 2006年第1期2卷 52-52页

作者： kikuchi Y. Matsui T. Hisabe T. 廖新华 Department of Gastroenterology Fukuoka University Chikushi Hospital 377-1 Ohaza Zokumyoin Chikushino 818-5807 Japan

Since 1997 we have experienced three cases of low-grade colonic mucosal-associated lymphoid tissue (MALT) lymphomas. The depth of tumor invasion was evaluated by endoscopic ultrasonography (EUS) and the mass lesions were all diagnosed as having extended beyond the deep region of the submucosal layer. Although all of these patients tested negative for gastric Helicobacter pylori, their tumor lesions regressed after antibiotic treatment in accordance with H. pylori eradication therapy. In general, consensus has been reached regarding antibiotic therapy for gastric MALT lymphomas. However, as a prerequisite for antibiotic therapy, the therapy has been deemed effective against these gastric tumors if the extent of infiltration, as evaluated by EUS, is limited to the mucosal layer or the superficial region of the submucosal layer. Based on the therapeutic outcomes seen in the three patients studied here, it is suggested that antibiotic therapy might be useful in treating MALT lymphomas of the colon, even in patients with advanced invasive tumors, in contrast to the extent of the lesions in the stomach suitable for antibiotic treatment. The success of the antibiotic treatment also suggests that MALT lymphomas may be caused by unknown luminal microorganisms, other than H. pylori.

关键词：结肠淋巴瘤 MALT 超声内镜浸润范围胃肿瘤黏膜层肿瘤浸润深度浸润性肿瘤胃幽门螺杆菌患

船用发动机有害排放气体的评价及处理研究──燃料性质和输出轴扭矩变化对发动机排放特性的影响

在线全文

学校读者我要写书评

暂无评论

内燃机学报 2000年第1期18卷 33-39页

作者：张洁高杉喜雄菊地正晃桑原孙四郎西尾澄人石村惠以子中岛康晴盐出敬二郎山谷周二西川和美日本国运输省船舶技术研究所机关动力部船舶技术研究所材料加工部

为了评价船用发动机有害气体的排放，本文从燃料的性质着手，较为详细地对不同性质的１３种燃料进行了研究，并在一台中型四冲程船用柴油机上进行了试验，测定了各种有害排气的浓度、发动机的性能和燃烧特性，对燃料的性质与排放之间... 详细信息

为了评价船用发动机有害气体的排放，本文从燃料的性质着手，较为详细地对不同性质的１３种燃料进行了研究，并在一台中型四冲程船用柴油机上进行了试验，测定了各种有害排气的浓度、发动机的性能和燃烧特性，对燃料的性质与排放之间的相关性进行了探讨。进一步调查研究了柴油机运转工况的不同及输出轴扭矩的变化对ＮＯｘ排放的影响。由试验结果可知：对于周期性输出扭矩的变化，ＮＯｘ的排放也发生周期性的变化。但是，柴油机在高输出区域运转时，随着扭矩增加所换算的ＮＯｘ浓度呈减小的趋势；反之，在低输出区域运转时，呈增加的趋势；输出扭矩周期性变化时的ＮＯｘ。的浓度可以用与其相对应的平均负荷状态的ＮＯｘ浓度处理。

关键词：船用柴油机有害排气 A重油 C重油氮氧化物

尿白蛋白排泄率作为接受降压治疗患者的残余心血管病风险分层指标的效用

在线全文

学校读者我要写书评

暂无评论

中华高血压杂志 2021年第10期29卷 946-946页

作者：袁源(摘译) 郑武洪(审校) kikuchi Y Tanaka F Nakamura M Tanno K Onoda T Ohsawa M Sakata K Omama S Ogasawara K Yonekura Y Itai K Kuribayashi T Ishigaki Y Okayama A Asahi K 不详

接受降压药物治疗的患者,即使血压控制良好,与非高血压个体的理想风险水平相比,仍有较高的风险发展为动脉粥样硬化性心血管病(atherosclerotic cardiovascular disease,ASCVD)。本文研究假设残余风险可以根据尿白蛋白排泄率(urinary alb... 详细信息

接受降压药物治疗的患者,即使血压控制良好,与非高血压个体的理想风险水平相比,仍有较高的风险发展为动脉粥样硬化性心血管病(atherosclerotic cardiovascular disease,ASCVD)。本文研究假设残余风险可以根据尿白蛋白排泄率(urinary albumin excretion,UAE)进行分层。方法:共纳入13082例血压<160/100 mm Hg(1 mm Hg=0.133 kPa).

关键词：尿白蛋白排泄率残余风险降压治疗动脉粥样硬化性心血管病心血管病风险 UAE 血压控制风险水平

血浆亲环蛋白A水平对冠状动脉疾病患者预后的影响

在线全文

学校读者我要写书评

暂无评论

中华高血压杂志 2017年第2期25卷 199-199页

作者： Ohtsuki T Satoh K Omura J kikuchi N Satoh T Kurosawa R Nogi M Sunamura S Yaoita N Aoki T Tatebe S Sugimura K Takahashi J Miyata S Shimokawa H 刘莉叶鹏

氧化应激状态下,血管平滑肌细胞、炎症细胞分泌亲环蛋白A（cyclophilin A,CyPA）,并激活血小板功能。最近研究表明,血浆CyPA水平是诊断冠状动脉疾病的新型生物标志物。血浆CyPA水平对这些患者的预后是否有影响仍未阐明。方法：连续纳入... 详细信息

氧化应激状态下,血管平滑肌细胞、炎症细胞分泌亲环蛋白A（cyclophilin A,CyPA）,并激活血小板功能。最近研究表明,血浆CyPA水平是诊断冠状动脉疾病的新型生物标志物。血浆CyPA水平对这些患者的预后是否有影响仍未阐明。方法：连续纳入接受诊断性冠状动脉造影的患者511例,测定血浆CyPA水平、高敏C反应蛋白（high-sensitivity C-reactive protein,hsCRP）和血浆脑钠尿肽水平,

关键词：冠状动脉疾病亲环蛋白A 血浆患者预后血管平滑肌细胞高敏C反应蛋白 protein

日本全国范围内各种显像剂实际使用剂量的调查报告

在线全文

学校读者我要写书评

暂无评论

中华核医学与分子影像杂志 2017年第7期37卷 445-445页

作者：唐军 Hiroshi Watanabe Kazunari Ishii Makoto Hosono Etsuko Imabayashi Koichiro Abe Masayuki Inubushi Kazuko Ohno Yasuhiro Magata Kinya Ono Kei kikuchi Kei Wagatsuma Tadashi Takase Kyoko Saito Yasuyuki Takahashi 苏州大学附属第二医院核医学科 Department of Radiological Technology Japan Labour Health and Welfare Organization Yokohama Rosai Hospital Department of Radiology Kindai University Faculty of Medicine

目的医疗照射的最优化在世界范围内都是辐射防护所关心的重要问题之一,国际辐射防护委员会和国际原子能机构推荐建立显像剂使用的剂量参考水平（DRLs）作为控制医疗照射最优化的工具。因此,根据最新调查资料构建DRLs已成为各核医学相关... 详细信息

目的医疗照射的最优化在世界范围内都是辐射防护所关心的重要问题之一,国际辐射防护委员会和国际原子能机构推荐建立显像剂使用的剂量参考水平（DRLs）作为控制医疗照射最优化的工具。因此,根据最新调查资料构建DRLs已成为各核医学相关学会和组织的迫切需要。为构建此DRLs,本研究在全日本范围内调查了核医学成人用显像剂的实际使用剂量。方法调查在2014年11月25日至2015年1月16日间进行,使用调查表方式调查了全日本1249个医疗单位各种显像剂的使用情况,调查结果通过网络反馈收集。结果 516个医疗单位反馈了调查结果,反馈率41%。具体显像包括:99Tcm-MDP和99Tcm-HMDP的骨显像,99Tcm-HM-PAO、99Tcm-ECD和123I-IMP的脑血流显像,99Tcm-Tetrofosmin、99Tcm-MIBI和201Tl-Cl的心肌灌注显像,18F-FDG(自产18F或配送的18F)的肿瘤PET显像。以上显像的第75百分剂量分别是为932、937、763、775、200、831、818、180、235和252 MBq。日本90%以上的医疗单位所使用的显像剂剂量在上述剂量值中位数的50%范围内。很多医疗机构采用包装说明书、文本或指南推荐的剂量,比如740 MBq(99Tcm-MDP和99Tcm-HMDP骨显像)、740 MBq(99Tcm-ECD和99Tcm-HM-PAO脑血流显像)和740 MBq(99Tcm-Tetrofosmin和99Tcm-MIBI心肌灌注显像)等。99Tcm-MDP和99Tcm-HMDP（用于骨显像）、99Tcm-HM-PAO（用于脑血流显像）、99TcmTetrofosmin和99Tcm-MIBI（用于心肌灌注显像）等许多显像剂的使用剂量均在欧盟DRLs内,且大多数在日本使用的显像剂剂量均未超过美国核医学与分子影像学会的标准使用剂量上限。结论本调查结果表明,在日本所使用的各种核医学显像剂的剂量比较集中,各医疗机构均能按照文本和指南要求的剂量越来越严格地使用显像剂。此外,日本显像剂的使用剂量均在欧盟和美国核医学与分子影像学会所规定的使用剂量范围内。

关键词：调查诊断参考水平放射性药物放射性活度剂量最优化

船用柴油机NO_x等有害排放气体的评价及处理研究——燃料喷射系统对乳化燃料在船用柴油机上使用的影响及脱硝装置的适用性

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

内燃机学报 2000年第4期18卷 380-386页

作者：张洁高杉喜雄菊池正晃桑原孙四郎西尾澄人石村惠以子中岛康晴盐出敬二郎山谷周二西川和美日本国运输省船舶技术研究所机关动力部船舶技术研究所材料加工部

对原试验用柴油机的燃料喷射系统进行了改造。改造后的燃料喷射系统不仅可降低 NOx 的排放 ,而且使高加水率乳化燃料的使用成为可能。但另一方面 ,在低负荷时 ,使用乳化燃料不但不能获得预期的降低 NOx 排放效果 ,反而使其它有害排放增... 详细信息

对原试验用柴油机的燃料喷射系统进行了改造。改造后的燃料喷射系统不仅可降低 NOx 的排放 ,而且使高加水率乳化燃料的使用成为可能。但另一方面 ,在低负荷时 ,使用乳化燃料不但不能获得预期的降低 NOx 排放效果 ,反而使其它有害排放增加。所以 ,也对降低 NOx 排放方法之一的脱硝装置进行了探讨 ,对其在船用柴油机上的适用性进行了试验。

关键词：燃料喷射系统船用柴油机乳化燃料排气污染

Pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis

在线全文

学校读者我要写书评

暂无评论

World Journal of Meta-Analysis 2019年第5期7卷 249-258页

作者： Mitsuru Sugimoto Tadayuki Takagi Rei Suzuki Naoki Konno Hiroyuki Asama Yuki Sato Hiroki Irie Ko Watanabe Jun Nakamura Hitomi kikuchi Mika Takasumi Minami Hashimoto Takuto Hikichi Hiromasa Ohira Department of Gastroenterology Fukushima Medical UniversitySchool of MedicineFukushima CityFukushima Prefecture 960-1295Japan Department of Endoscopy Fukushima Medical University HospitalFukushima CityFukushima Prefecture 960-1295Japan

BACKGROUND Endoscopic retrograde cholangiopancreatography(ERCP)plays a major role in the investigation and treatment of pancreaticobiliary ***,post-ERCP pancreatitis(PEP)is a severe adverse *** meta-analyses have shown that prophylactic PS was useful for preventing ***,abstract reports and patients who underwent endoscopic ampullectomy were included in the previous *** addition,two meta-analyses involved non-randomized controlled trials(RCTs).The efficacy of PS for preventing severe PEP was different in each ***,we performed the current metaanalysis,which included only full-text articles,and added new *** To reveal the efficacy of prophylactic pancreatic stent(PS)placement for preventing *** We searched the MEDLINE,Cochrane Library and PubMed databases for related *** the reports retrieved,11 studies were included in this *** full-text articles were published between 1993 and 2016.A total of 1475 patients were enrolled in the included studies;of these patients,734 had a PS inserted,and 741 did not have a PS *** and severe PEP occurrence were evaluated in this *** PEP was observed in all studies and occurred in 39(5.3%)patients who received a *** the other hand,PEP occurred in 141(19%)patients who did not receive a *** occurrence of PEP was significantly lower in the patients who underwent PS placement than in the patients who did not receive a PS(OR=0.32;95%CI:0.23-0.45;P<0.001).In addition,the occurrence of severe PEP was ***,the occurrence of severe PEP was not observed in the stent group;however,the occurrence of severe PEP was observed in 8(1.3%)patients who did not have a PS *** PEP occurred significantly less often in the stent group than in the no stent group(OR=0.24;95%CI:0.06-0.94;P=0.04).CONCLUSION In conclusion,prophylactic PS placement is useful for preventing PEP and severe PEP.

关键词： Endoscopic retrograde cholangiopancreatography Pancreatic stent Postendoscopic retrograde cholangiopancreatography pancreatitis Meta-analysis

Present state of endoscopic ultrasonography-guided fine needle aspiration for the diagnosis of autoimmune pancreatitis type 1

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Meta-Analysis 2019年第5期7卷 218-223页

作者： Mitsuru Sugimoto Tadayuki Takagi Rei Suzuki Naoki Konno Hiroyuki Asama Yuki Sato Hiroki Irie Ko Watanabe Jun Nakamura Hitomi kikuchi Mika Takasumi Minami Hashimoto Takuto Hikichi Hiromasa Ohira Department of Gastroenterology Fukushima Medical UniversitySchool of MedicineFukushima 960-1247Japan Department of Endoscopy Fukushima Medical University HospitalFukushima 960-1247Japan

Autoimmune pancreatitis(AIP)is defined as pancreatitis caused by irregular narrowing of the pancreatic duct accompanied by pancreatic swelling,fibrosis and lymphocyte infiltration,events that are related to autoimmune *** 2010 International Consensus Diagnostic Criteria for AIP defined pancreatitis as“type 1”when increased levels of serum IgG4 were present and other organs were involved;lymphoplasmacytic sclerosing pancreatitis was the main histological *** from surgery,endoscopic ultrasonographyguided fine needle aspiration(EUS-FNA)is the only method for the histological diagnosis of AIP;however,this method is *** use of larger-diameter FNA needles and trucut biopsy did not improve the diagnostic performance of EUS-FNA,but it has improved *** this review,we look back at past efforts to improve the diagnostic performance of EUS-FNA and reveal the present state of EUS-FNA for the histological diagnosis of AIP type 1.

关键词： Autoimmune pancreatitis type 1 Endoscopic ultrasonography-guided fine needle aspiration IgG4-related disease Lymphoplasmacytic sclerosing pancreatitis

Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis using pancreatic stents: A review of efficacy, diameter and length

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Meta-Analysis 2019年第6期7卷 259-268页

作者： Mitsuru Sugimoto Tadayuki Takagi Rei Suzuki Naoki Konno Hiroyuki Asama Yuki Sato Hiroki Irie Ko Watanabe Jun Nakamura Hitomi kikuchi Mika Takasumi Minami Hashimoto Takuto Hikichi Hiromasa Ohira Department of Gastroenterology Fukushima Medical UniversitySchool of Medicine Fukushima 9601247Japan Department of Endoscopy Fukushima Medical University HospitalFukushima 9601295Japan

Although endoscopic retrograde cholangiopancreatography (ERCP) is an important procedure for the diagnosis and treatment of pancreaticobiliary diseases, post-ERCP pancreatitis (PEP) is the most frequent adverse event that can sometimes be fatal. However, prophylactic pancreatic stent (PS) insertion has been performed to prevent PEP in high-risk patients. In some randomized controlled trials (RCTs) and meta-analyses, the efficacy of prophylactic PS insertion has been shown to prevent PEP. In addition, several types of stents have been used to decrease PEP. In this review, we introduce the details of these RCTs and meta-analyses and reveal the specifications for stent placement, for example, the stent diameter and length and the pancreatic region into which the stent should be inserted.

关键词： Endoscopic retrograde cholangiopancreatography Post-endoscopic retrograde cholangiopancreatography pancreatitis Prophylactic pancreatic stent